Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyThu, 02 May 2024 13:29:18 +0200Mon, 11 Mar 2024 14:09:00 +0100Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/comirnatyHuman medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/comirnatyMon, 11 Mar 2024 14:09:00 +0100Human medicineComirnaty : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5735-en_1.pdfComirnaty : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5735-en_1.pdfFri, 15 Dec 2023 16:31:00 +0100Human medicine